ARCHIVES

U. S. Oncologists To Audit Another Bezwoda Trial.

This article is from The Cancer Letter archive.

Vol. 26 No. 41 | November 10, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

October 3, 1986

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994